Scott Galloway mocks Morgan Stanley's $300 SpaceX target
Scott Galloway criticized Morgan Stanley's $300 SpaceX target, comparing it to fictional romance plots. The stock trades near $113, down from its $135 IPO. Analyst Adam Jonas bases his target on AI revenue growing to $319 billion by 2030. Prediction markets show low confidence in a near-term rebound above $120.

*this image is generated using AI for illustrative purposes only.
NYU professor Scott Galloway dismissed Morgan Stanley’s $300 price target on SpaceX (NASDAQ: SPCX) as unrealistic, suggesting the analyst behind the call is in the wrong profession. Speaking on the Prof G Markets podcast, Galloway remarked that the valuation logic resembles a romantic comedy rather than financial analysis. This critique arrives as SpaceX shares trade near $113, approximately 16% below their $135 IPO price and nearly 50% off an intraday high of $225.64.
The $300 target originates from Morgan Stanley analyst Adam Jonas, whose model projects revenue growth from $18.7 billion in 2025 to $319 billion by 2030. According to reports, more than half of this valuation relies on AI-driven data center ambitions and compute contracts with clients such as Anthropic and Google, rather than traditional rocket launches. Other Wall Street firms have issued varying targets: Goldman Sachs maintains a $205 target, while Raymond James analyst Brian Sigual holds a Street-high estimate of $800. Galloway’s co-host, Ed Elson, criticized Sigual’s view, noting it implies a $10.4 trillion market capitalization.
WeWork Parallels and Underwriter Conflicts
Galloway drew parallels between the current sentiment surrounding SpaceX and WeWork’s failed 2019 IPO. He recalled how underwriters at that time signed off on a prospectus using "community adjusted EBITDA," a metric that excluded real estate costs. Galloway labeled this approach "EBITDA before everything else" and warned against trusting institutions that fail to scrutinize such metrics. He highlighted a potential conflict of interest, noting that SpaceX’s reported IPO underwriters—including Goldman Sachs, JPMorgan, Bank of America, and Citigroup—all maintain buy ratings on the stock.
Prediction Markets and Upcoming Catalysts
Prediction markets reflect skepticism regarding a near-term rebound. Polymarket traders assign only a 21% probability of SpaceX closing July above $120 and just 2% odds of finishing above $140. The most likely outcome, priced at 60%, is a close above $110. Additionally, a separate contract offers 16% odds on a Tesla-SpaceX merger announcement by December 31, with nearly $880,000 in trading volume.
| Metric | Value/Probability |
|---|---|
| Current Price | ~$113 |
| IPO Price | $135 |
| Intraday High | $225.64 |
| July >$120 Odds | 21% |
| July >$140 Odds | 2% |
| Merger Odds (by Dec 31) | 16% |
SpaceX is scheduled to report its first public earnings on August 4. A lockup tranche of roughly 911 million shares is set to unlock two trading days later, on August 6. Analyst Adam Jonas has noted that many investors expect the stock to trade toward $100 as these lockups expire. Galloway also criticized Tesla Inc. (NASDAQ: TSLA), calling it a "meme stock" after its shares fell roughly 15% in a week.
How might the August 6 lockup expiration of 911 million shares impact SpaceX's stock price volatility and institutional holding patterns?
To what extent will the divergence between Wall Street's AI-driven revenue projections and traditional aerospace metrics influence long-term investor confidence?
Could the potential conflict of interest among IPO underwriters like Goldman Sachs and JPMorgan lead to stricter regulatory scrutiny of future tech IPOs?

































